Blog

6 December 2024 - More publicly funded medicines are on the way for people with types of breast and lung ...

1 December 2024 - As of 1 December 2024, combination chemotherapy medicines, Opdualag and Vyxeos, will be transitioned from the Highly ...

1 December 2024 - The December 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

1 December 2024 - For the first time in three decades, women living with endometriosis will now have access to ...

20 November 2024 - Australians with osteoporosis, a type of skin lymphoma, spinal muscular atrophy and type 2 diabetes will ...

12 November 2024 - PHARMAC has decided to fund the medicine empagliflozin for thousands of people with a type of ...

8 November 2024 - PHARMAC has decided to fund lenvatinib from 1 December 2024 for people with some types of ...

1 November 2024 - The November 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

1 November 2024 - The November 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

9 October 2024 - Columvi is now publicly covered in 7 provinces, which equates to approximately 74% of the total Canadian ...

10 October 2024 - PHARMAC will improve access to three cancer medicines from 1 November 2024. ...

4 October 2024 - Mike Lynch was only 12 when his mother died of cardiovascular disease, in the years following he ...

8 October 2024 - Australians with types of vasculitis, leukaemia, heart disease, ulcerative colitis and arthritis now have access to ...

4 October 2024 - A world-first cancer treatment, discovered in Melbourne, has been added to the PBS. ...